Theravalues Corp. is a leading biotechnology innovator in the healthcare and supplement industry. Based in Tokyo, Japan, it endeavors to offer value-driven consumer products, nutraceuticals and pharmaceuticals by using its scientific knowledge and R&D technologies. Its major two products, Theracurmin, one of the most advanced forms of curcumin in the marketplace, and EMIQ, a highly bioavailable quercetin glucosides, have been studied in various areas in human clinical trials and shown positive results with significant differences.
- Theracurmin (highly bioavailable curcumin)
- EMIQ (enzymatically modified isoquercitrin)